# The Efficacy of AP029 Mix in Patients With Impaired Carbohydrate Metabolism

> **NCT05994586** · NA · UNKNOWN · sponsor: **AronPharma Sp. z o. o.** · enrollment: 30 (estimated)

## Conditions studied

- Diabetes in Adolescence
- PreDiabetes

## Interventions

- **DIETARY_SUPPLEMENT:** AP029 mix
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05994586
- **Lead sponsor:** AronPharma Sp. z o. o.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-25
- **Primary completion:** 2023-11-26
- **Final completion:** 2023-11-26
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05994586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05994586, "The Efficacy of AP029 Mix in Patients With Impaired Carbohydrate Metabolism". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05994586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*